DHX Company Co., Ltd. (KOSDAQ:031860)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	16,360	25,191	44,300	59,469	59,414	70,871
Market Cap Growth	-1.37%	-43.13%	-25.51%	0.09%	-16.17%	43.71%
Enterprise Value	18,200	23,042	36,196	57,817	72,923	75,916
Last Close Price	953.00	1677.00	3400.00	6870.00	10300.00	13700.00
PS Ratio	1.54	2.64	3.98	7.12	2.70	4.55
PB Ratio	0.37	0.53	0.74	0.99	1.55	1.43
P/TBV Ratio	0.37	0.53	0.74	1.00	1.55	1.46
EV/Sales Ratio	1.72	2.41	3.25	6.93	3.31	4.87
Debt / Equity Ratio	0.18	0.11	0.05	0.25	0.55	0.16
Asset Turnover	0.18	0.16	0.15	0.11	0.35	0.24
Inventory Turnover	5.36	7.58	7.15	2.75	10.24	10.77
Quick Ratio	1.33	1.95	3.03	0.69	0.79	1.77
Current Ratio	2.39	2.58	3.95	1.06	0.99	2.16
Return on Equity (ROE)	-34.90%	-32.77%	-49.69%	-26.80%	-34.36%	-42.90%
Return on Assets (ROA)	-7.37%	-7.67%	-11.40%	-6.31%	-8.30%	-6.55%
Return on Capital (ROIC)	-7.80%	-8.11%	-12.33%	-6.97%	-8.98%	-6.84%
Earnings Yield	-105.69%	-69.82%	-71.63%	-24.39%	-25.54%	-19.93%
FCF Yield	-51.14%	-22.71%	-17.01%	-19.30%	-20.97%	-6.57%
Buyback Yield / Dilution	-37.57%	-42.23%	-30.06%	-37.90%	-12.04%	-110.40%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.